THE CHANGING ROLE OF CHEMISTRY IN DRUG DISCOVERY
This new report celebrating the end of the International Year of Chemistry
2011 delivers an action packed review of the changing role of the Chemist
in today's Pharmaceutical Research.
The Changing Role Of Chemistry In Drug Discovery — our new FREE report — delivers an action-packed review of the changing role of Chemistry and of Chemists in today's drug discovery research programs.
Drug discovery has changed significantly over the past 50 years — workflows have been reinvented, and new technologies have been employed while the same goals remain to find and test novel molecules that can reach and act on disease targets.
In this, the International Year of Chemistry (IYC 2011), Thomson Reuters offers a timely report that examines how life in drug discovery has changed and how it will continue to change and adapt in the future.
The report analyzes and develops the major themes identified and highlighted by key players in the global pharmaceutical industry. Many of their insights are fully supported by analysis of data taken from the Thomson Reuters IntegritySM drug discovery database for the period 2001-2011.
The Changing Role Of Chemistry In Drug Discovery discusses the following questions:
- Who will emerge as the major drug discoverers and the major drug developers during the next decade?
- What is the driver for change in the industry and will globalization and regulation have far reaching consequences for the role of the chemist?
- How will the numbers stack up in 2020 when we count the number of new chemical entities (NCEs): will the balance shift from conventional small molecule Pharma products to the burgeoning area of biologicals?
- How the future skills base will evolve and will there be a shift in the balance of traditional disciplines.
- Does a dearth of experience in Pharma, biotech, or academia impact on the changes and what role, if any, might the professional bodies play in the future development of the industry.
Download the report now to find out how current thoughts and trends in the industry may give insight into the future of the industry.
FIND OUT MORE ABOUT THOMSON REUTERS INTEGRITY.
Updated daily by scientists who analyze and index information from scientific meetings, literature, regulatory bodies, patents, and company reports, Integrity is designed to support chemists to make confident decisions, keep research focused, and foster innovation.
With Integrity you can:
- Create SAR tables at a click of a button
- Search for structural motifs of interest
- View the latest structures, scaffolds and synthetic routes emerging from patents
- Review executive summaries of therapeutic areas including targets, mechanisms, marketed drugs and pipeline information
Click here to find out more.
Quotes...
Parc Científic de Barcelona (PCB)
“If you are interested in early stage opportunities, I would recommend Thomson Reuters Integrity over other databases for the strength of its science." Dr Jay Kothari
Zydus Cadila Healthcare Ltd, India
